Search by Drug Name or NDC

    NDC 75834-0257-25 Atorvastatin calcium 40 mg/1 Details

    Atorvastatin calcium 40 mg/1

    Atorvastatin calcium is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by NIVAGEN PHARMACEUTICALS, INC.. The primary component is ATORVASTATIN.

    Product Information

    NDC 75834-0257
    Product ID 75834-257_0c732159-8fb2-35c5-e063-6394a90af246
    Associated GPIs 39400010100330
    GCN Sequence Number 029969
    GCN Sequence Number Description atorvastatin calcium TABLET 40 MG ORAL
    HIC3 M4D
    HIC3 Description ANTIHYPERLIPIDEMIC-HMGCOA REDUCTASE INHIB(STATINS)
    GCN 43722
    HICL Sequence Number 012404
    HICL Sequence Number Description ATORVASTATIN CALCIUM
    Brand/Generic Generic
    Proprietary Name Atorvastatin calcium
    Proprietary Name Suffix n/a
    Non-Proprietary Name Atorvastatin calcium
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 40
    Active Ingredient Units mg/1
    Substance Name ATORVASTATIN
    Labeler Name NIVAGEN PHARMACEUTICALS, INC.
    Pharmaceutical Class HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA213853
    Listing Certified Through 2024-12-31

    Package

    NDC 75834-0257-25 (75834025725)

    NDC Package Code 75834-257-25
    Billing NDC 75834025725
    Package 2500 TABLET in 1 BOTTLE (75834-257-25)
    Marketing Start Date 2020-08-26
    NDC Exclude Flag N
    Pricing Information N/A